🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

14+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 14 of 14 recruiting trials for “Severe acute respiratory syndrome”

NARecruitingNCT06099795 ↗

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

🏥 Centre Hospitalier Universitaire de Nīmes📍 2 sites📅 Started Jan 2025View details ↗
Phase 4RecruitingNCT06585241 ↗

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

🏥 ModernaTX, Inc.📍 6 sites📅 Started Sep 2024View details ↗
RecruitingNCT06168019 ↗

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

👨‍⚕️ Patricia Hibberd, MD PhD, Boston University School of Public Health, Global Health📍 2 sites📅 Started Dec 2023View details ↗
EARLY_Phase 1RecruitingNCT05656105 ↗

Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection

👨‍⚕️ Jonathan McConathy, MD, PhD, University of Alabama at Birmingham📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT05892549 ↗

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

🏥 Direction Centrale du Service de Santé des Armées📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05566483 ↗

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

🏥 University of Colorado, Denver📍 1 site📅 Started Mar 2023View details ↗
Phase 2, PHASE3RecruitingNCT05543616 ↗

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 134 sites📅 Started Sep 2022View details ↗
RecruitingNCT04705766 ↗

KIDney Injury in Times of COVID-19 (KIDCOV)

👨‍⚕️ Minnie Sarwal, M.D., Ph.D., University of California, San Francisco📍 3 sites📅 Started Mar 2021View details ↗
Phase 3RecruitingNCT04727424 ↗

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

👨‍⚕️ Gilmar Reis, MD,PhD., Cardresearch - Cardiologia Assistencial e de Pesquisa📍 12 sites📅 Started Jan 2021View details ↗
Enrolling by InvitationNCT04363047 ↗

Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19

🏥 University of Manchester📍 1 site📅 Started Oct 2020View details ↗
NARecruitingNCT04429594 ↗

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

🏥 Centre Hospitalier Universitaire de Nice📍 1 site📅 Started Jul 2020View details ↗
RecruitingNCT04579471 ↗

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

👨‍⚕️ Jef Verbeek, MD, PhD, UZ Leuven📍 1 site📅 Started Jul 2020View details ↗
RecruitingNCT04392401 ↗

COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study

👨‍⚕️ Fabienne VENET, Hospices Civils de Lyon📍 8 sites📅 Started May 2020View details ↗
Phase 3RecruitingNCT04381936 ↗

Randomised Evaluation of COVID-19 Therapy

👨‍⚕️ Peter W Horby, University of Oxford📍 7 sites📅 Started Mar 2020View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →